Radiation Oncology/Therapy: Page 415

NAS appoints new CFO
By AuntMinnie.com staff writers
Radiation therapy product developer North American Scientific has selected James Klingler as its chief financial officer and senior vice president.
July 12, 2004
BrainLab, Axeda partner
By AuntMinnie.com staff writers
Radiotherapy firm BrainLab has licensed device-relationship management (DRM) software and services from Axeda Systems.
July 11, 2004
Varian, Proxima team up for partial breast irradiation
By AuntMinnie.com staff writers
Varian Medical Systems and Proxima Therapeutics have formed an alliance. Under the terms of the deal, Proxima of Alpharetta, GA, will become the exclusive distributor of the Palo Alto, CA-based vendor's MammoSource HDR brachytherapy afterloader.
July 6, 2004
NeoRx files IND for radiotherapy agent
By AuntMinnie.com staff writers
Radiotherapy pharmaceutical developer NeoRx has filed an investigational new drug (IND) application with the Food and Drug Administration for a phase II clinical study of its Skeletal Targeted Radiotherapy (STR) product in patients with breast cancer that has metastasized to the bone, according to the Seattle-based vendor.
July 5, 2004
Varian reports first clinical use of robotic imager
By AuntMinnie.com staff writers
Varian Medical Systems said that Emory University School of Medicine's department of radiology has become the first U.S. healthcare facility to provide radiotherapy treatments using its robotic on-board imaging system for tracking tumor locations and positioning patients.
June 30, 2004
Philips expands R&D deal with Theseus
By AuntMinnie.com staff writers
Philips Medical Systems of Andover, MA, has expanded its research collaboration with Theseus Imaging regarding a tumor imaging radiopharmaceutical being developed by Theseus, a subsidiary of North American Scientific of Chatsworth, CA.
June 22, 2004
Postsurgical radiation improves prostate cancer survival
By AuntMinnie.com staff writers
A 13-year study of prostate cancer patients who underwent radical prostatectomy found that those who receive radiation therapy within six months of surgery live longer than those who are left untreated.
June 21, 2004
Radiation Therapy Services prices IPO
By AuntMinnie.com staff writers
Radiation treatment center operator Radiation Therapy Services said its initial public offering (IPO) of 5.5 million shares has been priced at $13 per share.
June 17, 2004
Varian plans stock split
By AuntMinnie.com staff writers
Varian Medical Systems has declared a two-for-one stock split.
June 13, 2004
Prowess, CPRS offer online treatment planning
By AuntMinnie.com staff writers
Radiation therapy provider Prowess is partnering with Comprehensive Physics & Regulatory Services (CPRS) to offer online treatment planning services.
June 10, 2004
Part II: Targeted MRI agents currently in development
The targeted MRI agents, like all imaging agents, carry limitations -- in this case the sensitivity of detection in images. Michael Tweedle, Ph.D., of the Academy of Molecular Imaging discusses where drug development applications are headed in the near future.
June 10, 2004
2004 06 04 11 02 41 706
Part I: Can biochemically targeted MRI agents improve drug development?
MRI agents are at an impasse, declares Michael Tweedle, Ph.D., of the Academy of Molecular Imaging, but changes are in the works. In Part I of this two-part series, Tweedle touts the allure of targeted MRI agents, and what they will mean to the future of cancer therapeutics.
June 10, 2004
2004 06 04 11 02 41 706
Previous Page
Page 415 of 468
Next Page